<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976530</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01</org_study_id>
    <nct_id>NCT04976530</nct_id>
  </id_info>
  <brief_title>Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)</brief_title>
  <acronym>STAR-T</acronym>
  <official_title>Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T): A Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate Reduction in Postoperative Bleeding by Removal of Ticagrelor With the Intraoperative Use of the DrugSorb-ATR Device in Patients Undergoing On-pump Cardiothoracic Surgery Within 48hrs From Last Ticagrelor Dose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CytoSorbents, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CytoSorbents, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and&#xD;
      effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients&#xD;
      undergoing cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 31, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of peri-operative bleeding</measure>
    <time_frame>Through the first 48hrs post-operation</time_frame>
    <description>Incidence of clinically significant peri-operative bleeding events, as evaluated by a ranked composite endpoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ticagrelor removal</measure>
    <time_frame>Through 30min post-CPB</time_frame>
    <description>Change in blood ticagrelor levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest tube drainage</measure>
    <time_frame>Through 24hrs post-operation</time_frame>
    <description>Drainage volume from all chest and mediastinal tubes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRBC transfusions (volume)</measure>
    <time_frame>Through to discharge from index hospitalization, on average 1-2 weeks</time_frame>
    <description>Total PRBC transfusions (mL) during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRBC transfusions (units)</measure>
    <time_frame>Through to discharge from index hospitalization, on average 1-2 weeks</time_frame>
    <description>Total PRBC transfusions (units) during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet transfusions (volume)</measure>
    <time_frame>Through to discharge from index hospitalization, on average 1-2 weeks</time_frame>
    <description>Total Platelet transfusions (mL) during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet transfusions (units)</measure>
    <time_frame>Through to discharge from index hospitalization, on average 1-2 weeks</time_frame>
    <description>Total Platelet transfusions (units) during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of moderate, severe, and massive peri-operative bleeding events</measure>
    <time_frame>Through the first day post-operation</time_frame>
    <description>Peri-operative bleeding events classified according to the Universal Definition of Peri-operative Bleeding, and analyzed by class (Class 0; 1; 2; 3; 4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-exploration for bleeding</measure>
    <time_frame>Through to discharge from index hospitalization, on average 1-2 weeks</time_frame>
    <description>All surgical re-explorations for excessive bleeding, as classified by an independent CEC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of fatal peri-operative bleeding</measure>
    <time_frame>Through to discharge from index hospitalization, on average 1-2 weeks</time_frame>
    <description>Deaths directly attributable to procedure-related bleeding, as adjudicated by an independent CEC</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hemorrhage, Surgical</condition>
  <condition>Blood Loss, Surgical</condition>
  <condition>Blood Loss, Postoperative</condition>
  <condition>Hemorrhage Postoperative</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Standard of care with Sham set-up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DrugSorb-ATR Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard of care + DrugSorb-ATR system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DrugSorb-ATR system</intervention_name>
    <description>Sorbent hemoperfusion system integrated into the cardiopulmonary bypass (CPB) circuit</description>
    <arm_group_label>DrugSorb-ATR Intervention</arm_group_label>
    <other_name>Sorbent hemoperfusion system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham comparator</intervention_name>
    <description>Sham comparator in similar position to the investigative device, but NOT integrated into the cardiopulmonary (CPB) circuit</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female 18 years of age or older, with documented full, written informed&#xD;
             consent&#xD;
&#xD;
          2. Requiring cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB) within 48hrs&#xD;
             of last ticagrelor intake&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. &gt;48hrs between last ticagrelor dose and start of CT surgery&#xD;
&#xD;
          2. Heart-lung transplant procedures&#xD;
&#xD;
          3. Procedures for ventricular assist device&#xD;
&#xD;
          4. Underlying bleeding diathesis&#xD;
&#xD;
          5. Prohibited concomitant antithrombotic medications as defined in the study protocol&#xD;
&#xD;
          6. Acute sickle cell crisis&#xD;
&#xD;
          7. Known allergy to device components&#xD;
&#xD;
          8. Active (untreated) systemic infection&#xD;
&#xD;
          9. History of major organ transplantation and those currently receiving immunosuppressive&#xD;
             medication or who are profoundly immune suppressed&#xD;
&#xD;
         10. Women with positive pregnancy test during current admission or who are lactating&#xD;
&#xD;
         11. Life expectancy &lt;30 days&#xD;
&#xD;
         12. Inability to comply with requirements of the study protocol&#xD;
&#xD;
         13. Treatment with investigational drug or device within 30 days of current surgery&#xD;
&#xD;
         14. Previous enrollment in this trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Mack, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor Scott &amp; White The Heart Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>C. M Gibson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center, The Baim Institute, and Harvard Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victoria Lee, MD</last_name>
    <phone>1-732-482-9995</phone>
    <email>vlee@cytosorbents.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>San Bernardine's in San Bernardino</name>
      <address>
        <city>San Bernardino</city>
        <state>California</state>
        <zip>92404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sherry Yee</last_name>
      <phone>909-475-5086</phone>
      <email>syee@soundphysicians.com</email>
    </contact>
    <investigator>
      <last_name>Howard Belzberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence St. John's Health Center</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sherry Yee</last_name>
      <phone>909-475-5086</phone>
      <email>syee@soundphysicians.com</email>
    </contact>
    <investigator>
      <last_name>Terese Hammond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Hospital of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yudmila B Tamayo, RN</last_name>
      <phone>786-596-5972</phone>
      <email>Yudmilab@baptisthealth.net</email>
    </contact>
    <investigator>
      <last_name>Charles Ma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph McGinn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital Midtown/Emory School of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcus T Wells</last_name>
      <phone>404-686-3343</phone>
      <email>marcus.terrell.wells@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caryn Bernstein, NP</last_name>
      <phone>404-605-5688</phone>
      <email>Caryn.Bernstein@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Vinod H Thourani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory Saint Joseph's Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristina Porte</last_name>
      <phone>678-843-5642</phone>
      <email>kristina.porte@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center/ UChicago Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Rodgers</last_name>
      <phone>773-702-5383</phone>
      <email>drodgers3@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Valluvan Jeevanandam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthey Audette</last_name>
      <phone>410-328-8149</phone>
      <email>maudette@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley Taylor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reney Henderson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annika Gallandt</last_name>
      <phone>617-643-9324</phone>
      <email>AGALLANDT@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Nathaniel B Langer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Debbie Conboy, RN</last_name>
      <phone>617-632-8135</phone>
      <email>dconboy@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>David Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Duane Pinto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amanda Kasperek, RN</last_name>
      <phone>734-615-9129</phone>
      <email>kasperea@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Himanshu J Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alex Driessche, MSE</last_name>
      <phone>313-916-4477</phone>
      <email>adriess1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Hassan Nemeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victor Coba, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amy McMeans</last_name>
      <phone>612-836-3895</phone>
      <email>amy.mcmeans@allina.com</email>
    </contact>
    <investigator>
      <last_name>Vinayak Bapat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jersey Shore University Medical Center</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne DeToro, RN</last_name>
      <phone>732-776-3499</phone>
      <email>Annemarie.detoro@hmhn.org</email>
    </contact>
    <investigator>
      <last_name>Richard Neibart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Illya Pushkar, MPH</last_name>
      <phone>347-420-2127</phone>
      <email>Illya.Pushkar@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Elias A Zias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel G Swistel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYPH/CUMC New York-Presbyterian Hospital/Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Alonso, MHA</last_name>
      <phone>212-342-0261</phone>
      <email>aa2974@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Argenziano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lori-Ann DeSimone, RN</last_name>
      <phone>401-444-5324</phone>
      <email>ldesimone@lifespan.org</email>
    </contact>
    <investigator>
      <last_name>Neel R Sodha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White The Heart Hospital Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Megan White, MS</last_name>
      <phone>469-814-4181</phone>
      <email>Megan.White1@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>J. M DiMaio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Sesera, RN</last_name>
      <phone>802-847-4746</phone>
      <email>Meghan.sesera@uvmhealth.org</email>
    </contact>
    <investigator>
      <last_name>Chris Rokkas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ambili John</last_name>
      <phone>540-521-8917</phone>
      <email>asjohn@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Joseph W Baker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Blood Loss, Surgical</mesh_term>
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

